Product image of Midodrine Biogaran (Midodrine Hydrochloride) supplied by GNH India

Midodrine Biogaran

Active Ingredient:
Midodrine Hydrochloride
Origin:
EU

Midodrine Biogaran (Midodrine Hydrochloride)

Midodrine Hydrochloride, the active ingredient in Midodrine Biogaran, is a alpha‑1 adrenergic agonist presented as a tablet for oral use. It is indicated for the management of orthostatic hypotension, helping to raise standing blood pressure and reduce dizziness, light‑headedness, and fainting episodes in adult patients.

GNH India supplies Midodrine Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation, ensuring reliable access to this prescription‑only vasopressor for healthcare providers across global markets.

Manufacturer / TM Owner

Biogaran

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Midodrine Biogaran is employed in the treatment of disorders characterized by inadequate vascular tone, primarily orthostatic hypotension, by stimulating alpha‑1 adrenergic receptors to increase peripheral resistance and raise blood pressure upon standing.

  • Orthostatic hypotension: Improves standing blood pressure and reduces symptoms such as dizziness, light‑headedness, and fainting.

How It Works

  • Midodrine is a pro‑drug that is rapidly converted by intestinal and hepatic enzymes to desglymidodrine, an active metabolite that selectively binds to peripheral alpha‑1 adrenergic receptors. This binding induces vasoconstriction of arterioles and veins, increasing systemic vascular resistance and thereby elevating arterial blood pressure, especially in the upright position. The effect is dose‑dependent and diminishes when the patient lies down, reducing the risk of excessive hypertension in the supine position.

Side Effects

Midodrine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Supine hypertension: increase in blood pressure while lying down.
  • Piloerection: goose‑flesh skin reaction.
  • Pruritus: itching sensation.
  • Urinary retention: difficulty emptying the bladder.

Serious or Rare Side Effects

  • Severe hypertension: marked elevation of blood pressure requiring medical attention.
  • Cardiac arrhythmia: irregular heart rhythm that may be life‑threatening.
  • Anaphylaxis: acute allergic reaction with potential airway compromise.

Precautions & Warnings

When prescribing Midodrine, clinicians should observe several safety considerations.

  • Monitor supine blood pressure: check for hypertension when patient is lying down.
  • Avoid use in severe cardiac disease: patients with uncontrolled heart failure or ischemic heart disease may be at risk.
  • Use caution in renal impairment: dose adjustment may be needed in reduced kidney function.
  • Review concomitant antihypertensive therapy: concurrent drugs may blunt the intended effect or cause excessive pressure changes.
  • Store at ambient temperature: keep tablets in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Midodrine can interact with other medicines, influencing blood pressure control.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): combined use may precipitate hypertensive crisis.
  • Other vasopressors: additive pressor effect can cause severe hypertension.
  • Sympathomimetic agents: risk of excessive increase in vascular tone.

Moderate Interactions (Monitor Closely)

  • Diuretics: may enhance orthostatic hypotension when standing.
  • Beta‑blockers: can blunt compensatory tachycardia, affecting blood pressure response.
  • Anticholinergic drugs: may increase risk of urinary retention.

Frequently Asked Questions

Midodrine Biogaran is prescribed for the treatment of orthostatic hypotension, a condition where blood pressure falls upon standing. By increasing vascular tone, it helps maintain adequate blood pressure and reduces symptoms such as dizziness, light‑headedness, and fainting in adult patients.

Midodrine Hydrochloride is a pro‑drug that is converted to desglymidodrine, which selectively activates peripheral alpha‑1 adrenergic receptors. This activation causes vasoconstriction of veins and arteries, raising systemic vascular resistance and consequently increasing standing blood pressure.

The appropriate dose of Midodrine Biogaran is determined by the prescribing healthcare professional based on the individual’s clinical condition, response, and tolerability. Dosage adjustments are made according to blood pressure measurements and patient-specific factors.

Midodrine is classified as pregnancy category unknown, and there is limited data on its use during lactation. Caution is advised, and the drug should only be used if the potential benefit justifies any possible risk to the fetus or infant.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Midodrine Biogaran. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Midodrine differs from agents such as fludrocortisone or droxidopa by directly stimulating alpha‑1 receptors to cause vasoconstriction, whereas fludrocortisone increases plasma volume and droxidopa is a norepinephrine precursor. Choice of therapy depends on patient comorbidities, response, and side‑effect profile.

Midodrine Biogaran tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure they are out of reach of children.

The medication is taken orally as a tablet with a glass of water. It is usually administered during the day, and patients are advised to avoid taking it within four hours of lying down to reduce the risk of supine hypertension.

The most critical adverse events include supine hypertension, severe hypertension, and cardiac arrhythmias. Patients should be monitored for sudden increases in blood pressure while lying down and for any signs of irregular heart rhythm.

Midodrine is contraindicated in patients with severe organic heart disease, uncontrolled hypertension, acute renal failure, or known hypersensitivity to the drug. It should also be used with caution in individuals with urinary retention or prostate enlargement.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.